help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davidson, B.
Right arrow Articles by Maloof, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davidson, B.
Right arrow Articles by Maloof, F.

Endocrinology, Vol 103, 871-882, Copyright © 1978 by Endocrine Society

ARTICLES

The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings

B Davidson, M Soodak, JT Neary, HV Strout, JD Kieffer, H Mover and F Maloof

A reinvestigation of the mechanism of action of methylmercaptoimidazole, propylthiouracil, and thiouracil on thyroid peroxidase (TPO) was undertaken. A preliminary incubation of TPO and H2O2 with methylmercaptoimidazole, propylthiouracil, or thiouracil was carried out in the absence of oxidizable substrates (i.e. I- or guaiacol). This incubation resulted in irreversible inactivation of TPO. The extent of inactivation could be determined after removal of the drug by gel filtration or by dilution into the assay mixture. Preincubation, as above, in the presence of iodide or thiocyanate prevented the irreversible inactivation of TPO. Rats receiving doses of these drugs which completely inhibited protein-bound iodine formation showed normal levels of TPO in their thyroid glands 30 min after drug administration. These findings suggest that the initial in vivo action of these drugs is to block iodination by trapping oxidized iodide, not by acting as "general inhibitors" of the TPO.


This article has been cited by other articles:


Home page
 EndocrinologyHome page
C. Schmutzler, A. Bacinski, I. Gotthardt, K. Huhne, P. Ambrugger, H. Klammer, C. Schlecht, C. Hoang-Vu, A. Gruters, W. Wuttke, et al.
The Ultraviolet Filter Benzophenone 2 Interferes with the Thyroid Hormone Axis in Rats and Is a Potent in Vitro Inhibitor of Human Recombinant Thyroid Peroxidase
Endocrinology, June 1, 2007; 148(6): 2835 - 2844.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. J. Degitz, G. W. Holcombe, K. M. Flynn, P. A. Kosian, J. J. Korte, and J. E. Tietge
Progress towards Development of an Amphibian-Based Thyroid Screening Assay Using Xenopus laevis. Organismal and Thyroidal Responses to the Model Compounds 6-Propylthiouracil, Methimazole, and Thyroxine
Toxicol. Sci., October 1, 2005; 87(2): 353 - 364.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. S. Cooper
Antithyroid Drugs
N. Engl. J. Med., March 3, 2005; 352(9): 905 - 917.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1978 by The Endocrine Society